Journal of Clinical Medicine · 2022 · 12 citations · 15 references
MedicinePharmacologyPharmacotherapyContraceptionReproductive EndocrinologyReproductive MedicineContraceptive CareContraceptive EffectivenessContraceptive MethodsContraceptive PharmacotherapyFemale ContraceptionHormonal ContraceptionComparative Contraceptive EffectivenessEstrogen-progestin ContraceptionHormonal Contraception-related BleedingHormonal Contraceptive TherapyP-valuesPrescribed DoseProgestin-only Regimens
(1) Background: Progesterone-only pills (POP) are widely used contraceptives. About 40% of women taking these pills report vaginal bleeding/spotting; 25% find this a reason for cessation. To date, no effective remedy has been described. We aimed to examine the therapeutic approaches offered by health providers. (2) Methods: A prospective questionnaire-based study of women experiencing vaginal bleeding due to POP, comparing the effectiveness of prescribed therapies. Women were recruited through social networks, and subsequently divided into groups according to the treatment offered: (1) POP with norethisterone (n = 36); (2) double dose POP (n = 19); (3) single dose POP (continuing initial treatment, n = 57); and (4) different POP formula (n = 8). Women rated bleeding quantity and frequency at four intervals, at weeks 0, 2, 4, and 6. (3) Results: Women who added 5 mg norethisterone acetate reported a significant decrease in bleeding frequency compared to the other groups, observed after 2, 4, and 6 weeks (p-values 0.019, 0.002, and 0.002, respectively). Women also reported an overall decrease in combined bleeding quantity and frequency (p-values 0.028, 0.003, and 0.005, respectively). There was no difference in the rate of side effects among groups. (4) Conclusions: Adding 5 mg norethisterone acetate (Primolut-nor) to progesterone-only pills significantly reduces bleeding and spotting associated with POP contraception.
15
U.S. Medical Eligibility Criteria for Contraceptive Use, 2016
Kathryn M. Curtis, Naomi K. Tepper, Tara C. Jatlaoui et al. · MMWR Recommendations and Reports · 2016 · 1.5K citations · Full text
Medicine, Gynecology, Obstetrics +15
Three-year continuation of reversible contraception
Justin T. Diedrich, Qiuhong Zhao, Tessa Madden et al. · American Journal of Obstetrics and Gynecology · 2015 · 130 citations · Full text
Medicine, Gynecology, Obstetrics +14